There is a risk of hepatitis flares when treatment is stopped post-partum, with modest ALT elevations (e.g. with ALT rise to >2x upper limit of normal) in more than one-third of women,74,75 of whom some may seroconvert to anti-HBe or even lose HBsAg, and others may become eligible for long-term therapy. This evidence concerns the gene GPT and hepatitis A virus infection.